Veronica Tebbs

804 total citations
8 papers, 524 citations indexed

About

Veronica Tebbs is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, Veronica Tebbs has authored 8 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Dermatology, 3 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Veronica Tebbs's work include Psoriasis: Treatment and Pathogenesis (2 papers), Dermatology and Skin Diseases (2 papers) and Nonmelanoma Skin Cancer Studies (2 papers). Veronica Tebbs is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (2 papers), Dermatology and Skin Diseases (2 papers) and Nonmelanoma Skin Cancer Studies (2 papers). Veronica Tebbs collaborates with scholars based in Germany, Spain and United Kingdom. Veronica Tebbs's co-authors include Luis Requena, Amaro García Díez, B. Cribier, J. Reifenberger, H. Schulze, Carlos Ferrándiz, Scott McRae, Ignasi Pau‐Charles, Peter van de Kerkhof and Jacek C. Szepietowski and has published in prestigious journals such as Clinical Cancer Research, British Journal of Dermatology and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Veronica Tebbs

8 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronica Tebbs Germany 6 241 211 181 117 96 8 524
Graziella Babino Italy 13 122 0.5× 243 1.2× 91 0.5× 120 1.0× 37 0.4× 40 423
Caius Solovan Romania 9 107 0.4× 86 0.4× 53 0.3× 93 0.8× 96 1.0× 51 350
Luca Mastorino Italy 15 275 1.1× 334 1.6× 69 0.4× 76 0.6× 70 0.7× 77 547
M.R. JUDGE United Kingdom 12 102 0.4× 165 0.8× 64 0.4× 30 0.3× 113 1.2× 27 503
Sonia Sofìa Ocampo‐Garza Mexico 12 86 0.4× 161 0.8× 58 0.3× 46 0.4× 72 0.8× 31 335
Eun Byul Cho South Korea 13 47 0.2× 239 1.1× 77 0.4× 32 0.3× 60 0.6× 40 437
Channy Muhn Canada 11 198 0.8× 369 1.7× 233 1.3× 54 0.5× 29 0.3× 27 580
Adele Haimovic United States 10 35 0.1× 212 1.0× 114 0.6× 81 0.7× 324 3.4× 22 802
Hiroo Amano Japan 13 93 0.4× 191 0.9× 84 0.5× 57 0.5× 82 0.9× 48 437
J Wasserman Sweden 16 211 0.9× 39 0.2× 75 0.4× 150 1.3× 54 0.6× 38 477

Countries citing papers authored by Veronica Tebbs

Since Specialization
Citations

This map shows the geographic impact of Veronica Tebbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Tebbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Tebbs more than expected).

Fields of papers citing papers by Veronica Tebbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Tebbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Tebbs. The network helps show where Veronica Tebbs may publish in the future.

Co-authorship network of co-authors of Veronica Tebbs

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Tebbs. A scholar is included among the top collaborators of Veronica Tebbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Tebbs. Veronica Tebbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Piraccini, Bianca Maria, Ulrike Blume‐Peytavi, M. Falqués, et al.. (2021). Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology. 36(2). 286–294. 75 indexed citations
3.
Mrowietz, Ulrich, Jacek C. Szepietowski, Robert Loewe, et al.. (2016). Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®- and placebo-controlled trial (BRIDGE). British Journal of Dermatology. 176(3). 615–623. 100 indexed citations
4.
Paul, C., J.F. Stalder, Diamant Thaçi, et al.. (2011). Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology. 26(4). 448–455. 22 indexed citations
5.
Dummer, Reinhard, Axel Hauschild, Juergen C. Becker, et al.. (2008). An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma. Clinical Cancer Research. 14(3). 856–864. 95 indexed citations
6.
Gollnick, Harald, Carlos Guillén Barona, Thomas Ruzicka, et al.. (2006). Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.. PubMed. 15(5). 374–81. 55 indexed citations
7.
Schulze, H., B. Cribier, Luis Requena, et al.. (2005). Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. British Journal of Dermatology. 152(5). 939–947. 167 indexed citations
8.
Matts, S. G. Flavell, B L Hazleman, H. Houben, Elisabeth Dhondt, & Veronica Tebbs. (1993). Controlled study of once-daily, sustained-release ibuprofen in osteoarthritis. Current Therapeutic Research. 53(4). 394–400. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026